Another presidential advisory committee appears to be breaking up. Continue reading →

President Donald Trump’s turnabout on the violence in Charlottesville has rocked his administration, leading to rising speculation that some top officials may be looking for a way out. Continue reading →

Since Saturday, seven CEOs resigned from the president’s Manufacturing Jobs Initiative panel after Trump blamed both sides for the weekend violence in Charlottesville, Va. Continue reading →

In a statement, the boss of one the America’s largest pharmaceutical companies, resigned from Trump’s council, citing “a responsibility to take a stand against intolerance and extremism.” Continue reading →

Drugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus. Continue reading →

Drugmaker Merck & Co. said that it will advance a new cancer drug into bigger patient tests, after promising findings in an early study. Continue reading →

Bladder Cancer Canada says it is deeply concerned about the shortage of a drug critical to treating the common malignancy. Continue reading →

Merck & Co. won the first U.S. approval for a new kind of cancer drug with big advantages over chemotherapy and other older cancer treatments. Continue reading →

Authorities say they still don’t know what caused more than 200 girls in El Carmen de Bolivar to come down in recent weeks with symptoms ranging from fainting to numbness in the hands and headaches. Continue reading →